Logo image of IAS

INTEGRAL AD SCIENCE HOLDING (IAS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:IAS - US45828L1089 - Common Stock

10.28 USD
+0.02 (+0.19%)
Last: 12/5/2025, 8:26:56 PM
10.28 USD
0 (0%)
After Hours: 12/5/2025, 8:26:56 PM
Fundamental Rating

6

IAS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 98 industry peers in the Media industry. IAS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IAS has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year IAS was profitable.
IAS had a positive operating cash flow in the past year.
In multiple years IAS reported negative net income over the last 5 years.
IAS had a positive operating cash flow in each of the past 5 years.
IAS Yearly Net Income VS EBIT VS OCF VS FCFIAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

IAS has a Return On Assets of 3.87%. This is in the better half of the industry: IAS outperforms 74.49% of its industry peers.
The Return On Equity of IAS (4.23%) is better than 66.33% of its industry peers.
With a Return On Invested Capital value of 3.81%, IAS perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IAS is significantly below the industry average of 7.98%.
The 3 year average ROIC (2.15%) for IAS is below the current ROIC(3.81%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.87%
ROE 4.23%
ROIC 3.81%
ROA(3y)1.74%
ROA(5y)-0.65%
ROE(3y)2.15%
ROE(5y)-1.58%
ROIC(3y)2.15%
ROIC(5y)N/A
IAS Yearly ROA, ROE, ROICIAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -5 -10

1.3 Margins

IAS's Profit Margin of 7.91% is fine compared to the rest of the industry. IAS outperforms 75.51% of its industry peers.
IAS has a Operating Margin of 10.67%. This is in the better half of the industry: IAS outperforms 62.24% of its industry peers.
The Gross Margin of IAS (77.42%) is better than 91.84% of its industry peers.
In the last couple of years the Gross Margin of IAS has remained more or less at the same level.
Industry RankSector Rank
OM 10.67%
PM (TTM) 7.91%
GM 77.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.89%
GM growth 5Y-1.46%
IAS Yearly Profit, Operating, Gross MarginsIAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IAS is destroying value.
IAS has more shares outstanding than it did 1 year ago.
IAS has more shares outstanding than it did 5 years ago.
IAS has a better debt/assets ratio than last year.
IAS Yearly Shares OutstandingIAS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
IAS Yearly Total Debt VS Total AssetsIAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 11.04 indicates that IAS is not in any danger for bankruptcy at the moment.
IAS's Altman-Z score of 11.04 is amongst the best of the industry. IAS outperforms 95.92% of its industry peers.
IAS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.04
ROIC/WACC0.45
WACC8.48%
IAS Yearly LT Debt VS Equity VS FCFIAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

IAS has a Current Ratio of 4.43. This indicates that IAS is financially healthy and has no problem in meeting its short term obligations.
IAS has a better Current ratio (4.43) than 97.96% of its industry peers.
A Quick Ratio of 4.43 indicates that IAS has no problem at all paying its short term obligations.
IAS has a Quick ratio of 4.43. This is amongst the best in the industry. IAS outperforms 97.96% of its industry peers.
Industry RankSector Rank
Current Ratio 4.43
Quick Ratio 4.43
IAS Yearly Current Assets VS Current LiabilitesIAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

IAS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.00%, which is quite impressive.
Looking at the last year, IAS shows a quite strong growth in Revenue. The Revenue has grown by 15.51% in the last year.
Measured over the past years, IAS shows a quite strong growth in Revenue. The Revenue has been growing by 19.95% on average per year.
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)15.51%
Revenue growth 3Y17.89%
Revenue growth 5Y19.95%
Sales Q2Q%15.6%

3.2 Future

Based on estimates for the next years, IAS will show a very strong growth in Earnings Per Share. The EPS will grow by 33.52% on average per year.
The Revenue is expected to grow by 12.02% on average over the next years. This is quite good.
EPS Next Y52.06%
EPS Next 2Y31.29%
EPS Next 3Y33.52%
EPS Next 5YN/A
Revenue Next Year14.52%
Revenue Next 2Y12.92%
Revenue Next 3Y12.39%
Revenue Next 5Y12.02%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
IAS Yearly Revenue VS EstimatesIAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
IAS Yearly EPS VS EstimatesIAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

IAS is valuated quite expensively with a Price/Earnings ratio of 32.13.
IAS's Price/Earnings ratio is a bit cheaper when compared to the industry. IAS is cheaper than 61.22% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.46, IAS is valued a bit more expensive.
The Price/Forward Earnings ratio is 25.93, which means the current valuation is very expensive for IAS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IAS is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 36.10. IAS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 32.13
Fwd PE 25.93
IAS Price Earnings VS Forward Price EarningsIAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

IAS's Enterprise Value to EBITDA is on the same level as the industry average.
67.35% of the companies in the same industry are more expensive than IAS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.86
EV/EBITDA 12.11
IAS Per share dataIAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IAS has a very decent profitability rating, which may justify a higher PE ratio.
IAS's earnings are expected to grow with 33.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.62
PEG (5Y)N/A
EPS Next 2Y31.29%
EPS Next 3Y33.52%

0

5. Dividend

5.1 Amount

IAS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTEGRAL AD SCIENCE HOLDING

NASDAQ:IAS (12/5/2025, 8:26:56 PM)

After market: 10.28 0 (0%)

10.28

+0.02 (+0.19%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-26 2026-02-26/amc
Inst Owners58.61%
Inst Owner Change1.32%
Ins Owners0.82%
Ins Owner Change29.05%
Market Cap1.73B
Revenue(TTM)590.67M
Net Income(TTM)46.72M
Analysts54
Price Target11.71 (13.91%)
Short Float %6.51%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)82.04%
Min EPS beat(2)11.7%
Max EPS beat(2)152.38%
EPS beat(4)3
Avg EPS beat(4)56.58%
Min EPS beat(4)-16.56%
Max EPS beat(4)152.38%
EPS beat(8)6
Avg EPS beat(8)49.12%
EPS beat(12)9
Avg EPS beat(12)-102.02%
EPS beat(16)11
Avg EPS beat(16)-73.47%
Revenue beat(2)2
Avg Revenue beat(2)2.78%
Min Revenue beat(2)2.42%
Max Revenue beat(2)3.15%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.81%
Max Revenue beat(4)3.15%
Revenue beat(8)7
Avg Revenue beat(8)1.18%
Revenue beat(12)11
Avg Revenue beat(12)1.79%
Revenue beat(16)15
Avg Revenue beat(16)2.09%
PT rev (1m)-1.72%
PT rev (3m)-11.71%
EPS NQ rev (1m)-1.01%
EPS NQ rev (3m)0.4%
EPS NY rev (1m)0%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0.23%
Revenue NQ rev (3m)0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 32.13
Fwd PE 25.93
P/S 2.92
P/FCF 12.86
P/OCF 9.73
P/B 1.56
P/tB 6.9
EV/EBITDA 12.11
EPS(TTM)0.32
EY3.11%
EPS(NY)0.4
Fwd EY3.86%
FCF(TTM)0.8
FCFY7.78%
OCF(TTM)1.06
OCFY10.28%
SpS3.52
BVpS6.58
TBVpS1.49
PEG (NY)0.62
PEG (5Y)N/A
Graham Number6.88
Profitability
Industry RankSector Rank
ROA 3.87%
ROE 4.23%
ROCE 5.55%
ROIC 3.81%
ROICexc 4.3%
ROICexgc 28.48%
OM 10.67%
PM (TTM) 7.91%
GM 77.42%
FCFM 22.72%
ROA(3y)1.74%
ROA(5y)-0.65%
ROE(3y)2.15%
ROE(5y)-1.58%
ROIC(3y)2.15%
ROIC(5y)N/A
ROICexc(3y)2.35%
ROICexc(5y)N/A
ROICexgc(3y)21.82%
ROICexgc(5y)N/A
ROCE(3y)3.13%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.89%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 62.98%
Cap/Sales 7.31%
Interest Coverage 250
Cash Conversion 134.81%
Profit Quality 287.27%
Current Ratio 4.43
Quick Ratio 4.43
Altman-Z 11.04
F-Score7
WACC8.48%
ROIC/WACC0.45
Cap/Depr(3y)52.63%
Cap/Depr(5y)38.91%
Cap/Sales(3y)6.28%
Cap/Sales(5y)5.42%
Profit Quality(3y)639.69%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y52.06%
EPS Next 2Y31.29%
EPS Next 3Y33.52%
EPS Next 5YN/A
Revenue 1Y (TTM)15.51%
Revenue growth 3Y17.89%
Revenue growth 5Y19.95%
Sales Q2Q%15.6%
Revenue Next Year14.52%
Revenue Next 2Y12.92%
Revenue Next 3Y12.39%
Revenue Next 5Y12.02%
EBIT growth 1Y25.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year255%
EBIT Next 3Y66.13%
EBIT Next 5Y41.75%
FCF growth 1Y98.17%
FCF growth 3Y15.7%
FCF growth 5YN/A
OCF growth 1Y79.1%
OCF growth 3Y22.84%
OCF growth 5YN/A

INTEGRAL AD SCIENCE HOLDING / IAS FAQ

Can you provide the ChartMill fundamental rating for INTEGRAL AD SCIENCE HOLDING?

ChartMill assigns a fundamental rating of 6 / 10 to IAS.


What is the valuation status of INTEGRAL AD SCIENCE HOLDING (IAS) stock?

ChartMill assigns a valuation rating of 5 / 10 to INTEGRAL AD SCIENCE HOLDING (IAS). This can be considered as Fairly Valued.


What is the profitability of IAS stock?

INTEGRAL AD SCIENCE HOLDING (IAS) has a profitability rating of 6 / 10.


What are the PE and PB ratios of INTEGRAL AD SCIENCE HOLDING (IAS) stock?

The Price/Earnings (PE) ratio for INTEGRAL AD SCIENCE HOLDING (IAS) is 32.13 and the Price/Book (PB) ratio is 1.56.


Can you provide the financial health for IAS stock?

The financial health rating of INTEGRAL AD SCIENCE HOLDING (IAS) is 8 / 10.